BeOne’s Commitment

Caregiver holding hand of man for support

We put patients first

At BeOne, “patients first” is more than a core value—it is our guiding principle. Every day, we strive to create high-quality, innovative medicines that are more affordable for patients. We work with cancer communities in the United States, Europe, Asia, and elsewhere around the globe to learn from patients, their families, and their care partners to help improve their lives by identifying and addressing their unmet needs.

We believe clinical trial transparency and data sharing supports biomedical innovation, increases broader awareness in clinical research, and fosters public trust in our products and treatments.

Global policy position on clinical research

BeOne is committed to the discovery and clinical development of new treatments that improve and extend life. As a global oncology company, we work in collaboration with various stakeholders including HCPs, healthcare organizations, patient organizations, and congress and other third-party organizations.

Leveraging an in-house approach to clinical research, a research and development team of industry-leading scientists and an international clinical development footprint enable us to efficiently develop innovative therapies that bring meaningful benefits to patients. We are committed to conducting our business activities with honesty, integrity, and transparency.

Patient-focused approach to clinical research

At BeOne, we believe in actively involving patients and care partners in our clinical research and development process. This helps us understand the real-life needs and challenges facing those living with cancer. By gaining the perspectives of patients and their care partners, we can design clinical trials to better reflect their needs and the outcomes that matter most.

Our approach to cancer biology unites cutting-edge research models and processes for drug discovery with the scale of a global organization. Our team of dedicated scientists in biology, chemistry, pharmacology, translational medicine, and clinical science are excited by the challenges of creating tomorrow’s medicines.

Diversity for clinical trials

People of different ages, genders, ethnic backgrounds, and genetic makeups can respond to the same treatment in different ways. That is why it is important to include people from all walks of life in clinical trials. This helps researchers find better treatments that work for everyone. At BeOne, we are committed to including diverse patient populations in our studies and conducting clinical trials across multiple geographic regions to help advance more effective treatments for all people.